1.The dose proportionality and bioavailability of the potential anti-inflammatory and neuroprotec-tive JNK inhibitor 11H-indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) were evaluated by comparing pharmacokinetic parameters after single oral (25, 50 and 100mg/kg) and intravenous (1mg/kg) IQ-1 administration in rats.2. IQ-1 and its major metabolite ketone 11H-indeno[1,2-b]quinoxalin-11-one (IQ-18) were isolated from plasma samples by liquid-liquid extraction. IQ-1 (E-isomer) and IQ-18 were simultaneously quantified in plasma by the validated method of liquid chromatography with triple quadrupole mass spectrometry (HPLC-MS/MS).3. The absolute bioavailability of IQ-1 was <1.5%. Cmax values were 24.72 +/- 4.30, 25.66 +/- 7.11 and 37.61 +/- 3.53ng/mL after single oral administration of IQ-1 at doses of 25, 50 and 100mg/kg, respectively. IQ-1 exhibited dose proportionality at 50-100mg/kg dose levels, whereas its pharma-cokinetics was not dose proportional over the range of 25-50mg/kg. IQ-18 demonstrated the invariance of the dose-normalized Cmax.4.In this study we systematically elucidated the absorption characteristics of IQ-1 in rat gastrointes-tinal tract and provided better understanding of IQ-1 pharmacology for the future development of a new formulations and therapeutic optimisation.
Background: IQ-1 is a promising c-Jun-N-terminal kinase inhibitor and nitrovasodilator. An LC–MS/MS method was validated to determine IQ-1 isomers and major metabolite IQ-18 in rat plasma. Material...
1 August 2020 in Russian Journal of Inorganic Chemistry
Interaction between the systems containing cobalt(II) or nickel(II) chlorides and 2-thiobarbituric acid (C4H4N2O2S, H2L) was examined by spectrophotometry and pH-metry at pH < 4, I = 0.1 (NaCl) and T = 20°C. The compositions and the overall stability constants (log β11) of protonated complex species were determined: [CoHL]+ (3.69 ± 0.04), [NiHL]+ (3.68 ± 0.08), and [M(HL)2]. The compositions of the Co(C4H3N2O2S)2 · 4H2O and Ni(C4H3N2O2S)2 · 5H2O salts isolated from the studied systems were confirmed by different physicochemical methods; their solubility constants (log KS) were calculated to be –12.82 ± 0.22 and –12.30 ± 0.10, respectively. A spectrophotometric technique was developed for determining thiobarbiturate ion in aqueous solutions. This technique is based on the absorbance of iron(III) thiobarbiturate complex [FeL]+ and can be recommended for analytical chemists and pharmacists.
1 January 2023 in Russian Journal of Inorganic Chemistry
Complexation in systems containing iron(III) chloride and barbituric (H2BA) or 2-thiobarbituric (H2TBA) acid has been studied by spectrophotometry and pH-metry in the pH range of 1.3–3.3 (I = 0.1 (NaCl), t = 20°C). The presence of 1 : 1 complexes with mono- and deprotonated forms of the ligand has been established, and their stability constants (in log units) have been determined: 1[FeHBA]2+ (3.49 ± 0.15), [FeHTBA]2+ (2.69 ± 0.07), [FeBA]+ (12.22 ± 0.13), and [FeTBA]+ (11.05 ± 0.08). It has been shown that the higher thermodynamic stability of barbiturate complexes compared to 2-thiobarbiturate ones is due to the greater basicity of the barbiturate anion. Based on the stability constants obtained, it has been proposed to use orthophosphate, fluoride, and ethylenediaminetetraacetate ions to eliminate the interfering effect of iron(III) in the determination of malondialdehyde by the thiobarbiturate method. Orthophosphoric acid is the most convenient for practical applications, as it makes it possible to mask iron(III) and to create a strongly acidic medium necessary for the formation of a colored malondialdehyde–H2TBA adduct.
Imidazolium barbiturate (two polymorphs, 1 and 2) and imidazolium 2-thiobarbiturate (3) with an unusual geometry of HB motifs were synthesized. Interestingly, 2 was more soluble in water than 3, while initial barbituric acids showed inverse tendency.